Zintevir is a DNA 17mer that forms a quadruplex and shows strong anti-human immunodeficiency virus (HTV)-1 activity. The quadruplex formation is thought to be essential for the anti-HIV-1 activity of Zintevir. We synthesized the enantiomer of Zintevir and evaluated its structure and anti-HIV-1 activity. The results showed that the enantiomer has anti-HIV-1 activity comparable to that of Zintevir although it forms the mirror image quadruplex structure of Zintevir.
INTRODUCTION
At present, the molecular targets of most of the clinically available anti-HTV agents are reverse transcriptase and protease. Since the emergence of viral strains resistant to these agents has become a serious issue in AIDS chemotherapy, the development of novel agents with other targets is desired. Zintevir ( Figure 1 ) is an anti-HIV-1-active DNA 17mer that has two phosphorothioate linkages at its two termini to improve in vivo stability (1) . The molecular target of Zintevir is thought to be viral gpl20 glycoprotein (2) . Some viral proteins, such as reverse transcriptase and tat protein, were reported to recognize some ligands (3-TC and enf-TAR RNA) that have chirality opposite to that of natural ligands (3, 4) . These findings suggest that these viral proteins may recognize their specific ligands with low or even no stereospecificity.
We synthesized the L-enantiomer (L-17mer) of Zintevir to compare its structure and anti-HIV-1 activity with those of Zintevir. 
RESULTS AND DISCUSSION
L-Thymidine, L-deoxyguanosine and their amidite derivatives were synthesized by a previously reported procedure (5) . The L-17mer was synthesized by the phosphoramidite method using an Applied Biosystems model 392 DNA synthesizer. In addition, DS-17mer (Zintevir) and D-17mer (all phosphodiesters) were synthesized as controls of the anti-HIV-1 activity and the structure, respectively.
*: phosphorothioate linkage Figure 2 shows the CD spectra of the 17mers measured in the presence of 0.2 M potassium chloride. DS-17mer was reported to form the quadruplex structure in this condition. The spectrum of D-17mer is very similar to that of DS-17mer, whereas L-17mer shows a spectrum that is completely symmetrical to that of D-17mer. This indicates that D-and DS-17mers form the similar quadruplex structure as reported, whereas L-17mer forms the mirror image structure of the quadruplex. The UV melting profiles of the 17mers were very similar to each other. Therefore, these ; 17mers have identical physicochemical properties other than the chirality of L-17mer. In order to compare the anti-HTV-1 activity of the 17mers, we tested the in vitro inhibitory effects of the 17mers on the HIV-1-induced cytopathicity in MT-4 cells. The inhibitory effects of DS-and L-17mers are almost the same, their IC S0 values being 0.225 yM, despite having opposite chiralities to each other, whereas that of D-17mer is 0.57 jiM. The difference in activity between the two former 17mers and the latter one may be explained by their resistance to nucleases in the culture medium and/or in the cells. Therefore, we investigated their susceptibility to nuclease PI and snake venom phosphodiesterase (SVPD). Given the same conditions, D-17mer was degraded rapidly, whereas DS-17mer was degraded gradually with the enzymes. In contrast, L-17mer is completely resistant to both enzymes. The lower anti-HTV-l activity of D17mer may reflect its susceptibility to degradation by nucleases.
The primary molecular target of DS-17mer (Zintevir) is thought to be the gpl20 glycoprotein, although it is known that it also inhibits HIV integrase. To verify the target of L-17mer within the HTV life cycle, the time-of-addition test was conducted. The results indicated that all 17mers exhibit the anti-HTV-l activity before viral invasion into host cells. This strongly suggests that the target of these 17mers is the process of viral entry into the host cells within the HTV replicative cycle. Furthermore, L-17mer inhibited more effectively the binding of the gpl2O-specific monoclonal antibody to MOLT-4 cells, which persistently infected with HTV-1, than DS-17mer. Thus, the primary molecular target of L-17mer would be the gpl20 glycoprotein as well. Comparative studies on the binding of the 17mers to gpl20 by using SPR (surface plasmon resonance) are currently under way.
